Industries Market Research Reports

Subscribe to RSS Feed
  1. 15 Oct 2024  |  Global  |  Technology Research

    Emerging Non-opioid Treatments for Pain Management

    Advances in Non-opioid Therapies for Neuropathic, Migraine, and Cancer Pain Management Unlock New Growth Opportunities

    The analysis explores cutting-edge advancements in non-opioid medications by delving into their mechanisms of action at a molecular scale, scrutinizing results from current clinical research initiatives, and appraising preparedness for and plausibility of regulatory approval. The considerations aim to highlight how these treatments may offer viable...

    $4,950.00
  2. 25 Jul 2024  |  Global  |  Technology Research

    Engineered Antibody Therapeutics for Cancer

    Technology advances and increasing interest from Tier I pharmaceuticals are driving the growth of engineered antibodies

    This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...

    $4,950.00
  3. 24 Jul 2024  |  Global  |  Technology Research

    Menopause Care Management Technology Growth Opportunities, 2024 2029

    Growing competitive intensity fuels future growth potential in menopause care management

    As the global population ages, more attention should be paid to the needs of individuals aged 45 to 55, particularly women in the perimenopausal and menopausal stages. Women aged 45 and above are at a crucial stage in terms of professional and personal responsibilities; however, they are challenged by menopausal symptoms, such as hot flashes, sleep...

    $4,950.00
  4. 20 Dec 2022  |  Global  |  Technology Research

    Advances and Growth Opportunities in RNA Vaccines

    Technology Innovations and Investments Bolster Next-generation Prophylactic and Therapeutic RNA Vaccines

    RNA therapeutics and vaccines have been around for a long time, but the COVID-19 pandemic enabled their mass-market commercialization. Industry players saw mRNA vaccines developed for COVID-19 as effective for reducing the impact of the SARS-CoV-2 virus in populations. Moderna emerged as the first player to develop and commercialize an mRNA vaccine...

    $4,950.00

    Special Price $3,712.50 save 25 %

  5. 09 Nov 2022  |  Global  |  Technology Research

    Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis

    Strategic partnering and new product development will enable better biologics for personalized and targeted treatment

    Muscle weakness, cramps, and impaired musculoskeletal functions that occur due to rare defects in nerve and muscle cells characterize neuromuscular disorders (NMDs). The disorders are largely classified as motor neuron diseases, hereditary ataxias, peripheral nerve disorders, neuromuscular junction transmission disorders, and myopathies. NMDs prese...

    $4,950.00

    Special Price $3,712.50 save 25 %

  6. 05 Sep 2022  |  Global  |  Technology Research

    Technology Growth Opportunities for Exosome-Mediated Drug Delivery

    Exosomes Are Promising Delivery Carriers for Advanced Therapeutics

    Exosome-mediated drug delivery is a promising alternative to conventional drug delivery methods, making rapid strides in the biopharmaceutical industry because of the safety and efficacy advantages exosomes offer as nanocarriers over synthetic nanoparticles. The widely explored concepts of nanomedicine, nucleic acid therapeutics, and cell-free vacc...

    $4,950.00

    Special Price $3,712.50 save 25 %